Amlodipine Besylate And Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 51407-858

7 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Olmesartan Medoxomil (NDC 51407-858). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine And Olmesartan (PI charts.jpg)

Amlodipine And Olmesartan (PI charts.jpg)
A series of four line graphs showing probabilities of achieving specific systolic and diastolic blood pressure targets at Week 8 using LOCF. The graphs compare placebo, amlodipine 10 mg, olmesartan medoxomil (OM) 40 mg, and a combination of amlodipine besylate and olmesartan medoxomil (AM/LOM) 10/40 mg. Each graph plots baseline blood pressure (SBP or DBP) against the percentage of patients achieving target BP thresholds: SBP < 140 mmHg, DBP < 90 mmHg, SBP < 130 mmHg, and DBP < 80 mmHg.*
FDA Label Image

The Structural Formula For Amlodipine Besylate Is Chemically Described As 3-ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, Monobenzene (Azor 05)

The Structural Formula For Amlodipine Besylate Is Chemically Described As 3-ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, Monobenzene (Azor 05)
Chemical structure of amlodipine besylate and olmesartan medoxomil indicating molecular components and arrangement, including the besylate moiety shown as part of the structure.*
FDA Label Image

The Structural Formula For Olmesartan Medoxomil Is Chemically Described As 2,3-dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1h-tetrazol-5-ylphenyl)benzyl]imidazole-5-carboxylate, C (Azor 06)

The Structural Formula For Olmesartan Medoxomil Is Chemically Described As 2,3-dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1h-tetrazol-5-ylphenyl)benzyl]imidazole-5-carboxylate, C (Azor 06)
Chemical structure diagram representing the active ingredients amlodipine besylate and olmesartan medoxomil. The structural formula shows molecular bonds and constituent atoms of the compounds.*
FDA Label Image

51407-857-30lb-amlodipine Olmesartan 5.20 Rev0426.jpg (51407 857 30lb Amlodipine Olmesartan 5.20 Rev0426)

51407-857-30lb-amlodipine Olmesartan 5.20 Rev0426.jpg (51407 857 30lb Amlodipine Olmesartan 5.20 Rev0426)
Label for amlodipine besylate and olmesartan medoxomil tablets, 5 mg/20 mg strength, film-coated oral tablets. The label shows a package size of 30 tablets and indicates prescription use only. Marketed by GSMS, Incorporated, with storage instructions and product origin noted as Germany.*
FDA Label Image

51407-858-30lb-amlodipine Olmesartan 10.20 Rev0426.jpg (51407 858 30lb Amlodipine Olmesartan 10.20 Rev0426)

51407-858-30lb-amlodipine Olmesartan 10.20 Rev0426.jpg (51407 858 30lb Amlodipine Olmesartan 10.20 Rev0426)
Label for amlodipine besylate and olmesartan medoxomil tablets, 10 mg/20 mg strength, oral film-coated tablets. The label shows a package containing 30 tablets, marketed by GSMS, Incorporated. Storage instructions and prescription-only designation are included, along with product origin from Germany. The NDC is 51407-858-30.*
FDA Label Image

51407-859-30lb-amlodipine Olmesartan 5.40 Rev0426.jpg (51407 859 30lb Amlodipine Olmesartan 5.40 Rev0426)

51407-859-30lb-amlodipine Olmesartan 5.40 Rev0426.jpg (51407 859 30lb Amlodipine Olmesartan 5.40 Rev0426)
Label for amlodipine besylate and olmesartan medoxomil tablets, strength 5 mg/40 mg, film-coated, oral tablets. The package contains 30 tablets for prescription use only. The product is marketed by GSMS, Incorporated, with storage instructions at controlled room temperature and manufactured in Germany.*
FDA Label Image

51407-860-30lb-amlodipine Olmesartan 10.40 Rev0426.jpg (51407 860 30lb Amlodipine Olmesartan 10.40 Rev0426)

51407-860-30lb-amlodipine Olmesartan 10.40 Rev0426.jpg (51407 860 30lb Amlodipine Olmesartan 10.40 Rev0426)
Label for amlodipine besylate and olmesartan medoxomil tablets in 10 mg/40 mg strength. The label indicates 30 film-coated tablets per container, marketed by GSMS, Incorporated, with storage instructions and a barcode. The product is noted as manufactured in Germany and Rx Only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.